Alkylating agents
Chemoradiotherapy + Stem Cell Transplant for Blood Cancers
Recruiting1 awardPhase 1 & 2
Duarte, California
This trial is giving chemotherapy drugs and HT before a donor stem cell transplant to see if it helps stop the growth of cancer cells and also helps stop the patient's immune system from rejecting the donor's stem cells.
JAK Inhibitor
Ruxolitinib + Chemotherapy for Leukemia
Recruiting1 awardPhase 2
Birmingham, Alabama
This trial is testing a new cancer drug, ruxolitinib, in combination with standard chemotherapy to treat B-cell acute lymphoblastic leukemia. The study will first find the best dose of ruxolitinib to use with chemotherapy, then test how well the combination works at that dose.
Cell Therapy
Stem Cell Transplant for Blood Cancers
Recruiting1 awardPhase 2
Philadelphia, Pennsylvania
This trial is testing a new stem cell transplantation method for people with blood cancers. The new method uses a machine to remove certain cells from the donor stem cells, and it also removes a different type of cell from the patient before transplant. The trial will measure how well the transplant works and how long the patient survives without the cancer coming back.
Popular Filters
Trials for Acute Myeloid Leukemia Patients
Bruton's Tyrosine Kinase (BTK) Inhibitor
PCI-32765 for Chronic Lymphocytic Leukemia
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing a new cancer treatment drug, PCI-32765, to see if it can treat chronic lymphocytic leukemia and small lymphocytic lymphoma in elderly people and people with 17p deletion.
CAR T-cell Therapy
Kappa CD28 T Cells for Leukemia
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a new treatment for patients with a type of cancer called NHL, Multiple Myeloma (MM) or CLL that has come back or has not gone away after treatment. The treatment is a gene transfer research study using special immune cells. The study is testing whether combining two different ways of fighting disease, antibodies and T cells, will be more effective than using either method alone.
Topoisomerase II inhibitors
IMRT + Chemotherapy + Stem Cell Transplant for Leukemia
Recruiting1 awardPhase 1 & 2
Duarte, California
This trial is giving IMRT with chemotherapy to patients with relapsed or refractory ALL or AML before a donor stem cell transplant. The aim is to find out the side effects of this treatment and the best dose of IMRT to give, as well as how well the IMRT and chemotherapy work in treating patients.
Trials for Acute Promyelocytic Leukemia Patients
Bruton's Tyrosine Kinase (BTK) Inhibitor
PCI-32765 for Chronic Lymphocytic Leukemia
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing a new cancer treatment drug, PCI-32765, to see if it can treat chronic lymphocytic leukemia and small lymphocytic lymphoma in elderly people and people with 17p deletion.
CAR T-cell Therapy
Kappa CD28 T Cells for Leukemia
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a new treatment for patients with a type of cancer called NHL, Multiple Myeloma (MM) or CLL that has come back or has not gone away after treatment. The treatment is a gene transfer research study using special immune cells. The study is testing whether combining two different ways of fighting disease, antibodies and T cells, will be more effective than using either method alone.
Topoisomerase II inhibitors
IMRT + Chemotherapy + Stem Cell Transplant for Leukemia
Recruiting1 awardPhase 1 & 2
Duarte, California
This trial is giving IMRT with chemotherapy to patients with relapsed or refractory ALL or AML before a donor stem cell transplant. The aim is to find out the side effects of this treatment and the best dose of IMRT to give, as well as how well the IMRT and chemotherapy work in treating patients.
Trials for CD19 Positive Patients
Stem Cell Transplantation
Stem Cell Transplant for Bone Marrow Failure Syndrome
Recruiting1 awardPhase < 1
Philadelphia, Pennsylvania
This trial is for children with a serious disease who are not eligible for other stem cell transplant protocols. The goal is to expand access for patients who lack a fully HLA matched sibling donor.
Phase 3 Trials
Probiotic
Probiotics for Preventing Graft-versus-Host Disease
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing whether Lactobacillus plantarum, a beneficial bacteria found in foods like yogurt, can prevent a serious gut complication called acute graft versus host disease in young patients receiving stem cell transplants. The bacteria may help by keeping the gut healthy and reducing inflammation. Lactobacillus plantarum has been used in human studies to promote beneficial effects in the immune system, alleviate intestinal disorders, and reduce the risk of cardiovascular disease. The study will compare patients taking Lactobacillus plantarum to those not taking it.
Chemotherapy
New Cancer Treatment for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 2 & 3
San Diego, California
This trial is testing a new cancer treatment for children with B-cell NHL. The new treatment is based on the successful LMB-96 regimen. The trial features prospective biologic and late effect studies.
Trials With No Placebo
Bruton's Tyrosine Kinase (BTK) Inhibitor
PCI-32765 for Chronic Lymphocytic Leukemia
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing a new cancer treatment drug, PCI-32765, to see if it can treat chronic lymphocytic leukemia and small lymphocytic lymphoma in elderly people and people with 17p deletion.
CAR T-cell Therapy
Kappa CD28 T Cells for Leukemia
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a new treatment for patients with a type of cancer called NHL, Multiple Myeloma (MM) or CLL that has come back or has not gone away after treatment. The treatment is a gene transfer research study using special immune cells. The study is testing whether combining two different ways of fighting disease, antibodies and T cells, will be more effective than using either method alone.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.